Chelsea Therapeutics International, Ltd.
CHTPTicker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Insider trading at Chelsea Therapeutics International, Ltd. (CHTP) refers to stock transactions executed by corporate insiders—officers, directors, and shareholders owning more than 10% of the company. Over the past 90 days, 21 insiders have filed 301 transactions totaling $37.0M in trading activity. The most active insider is Josiah T. Austin (Executive), contributing $18.3M across 117 transactions.
Chelsea Therapeutics International, Ltd. insiders are currently net buyers of CHTP stock, showing bullish sentiment over the past 90 days. Executives have purchased $33.5M while selling $3.5M, resulting in a positive net flow of $30.1M. This buying activity represents 91% of total transaction volume.
Chelsea Therapeutics International, Ltd. has 21 active insiders who have filed SEC Form 4 transactions in the past 90 days. Josiah T. Austin (Executive) leads with 117 transactions totaling $18.3M. Coronado Holdings, Llc El (Executive) follows with 75 transactions worth $14.9M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.
The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. Chelsea Therapeutics International, Ltd.'s current score of 91/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $33.5M in purchases versus $3.5M in sales.
The most recent insider transaction occurred on Jun 23, 2014, when D. Schwieterman William (Executive) disposed of 10,000 shares at $2.96 per share for $29.6K. This appears to be a discretionary trade.
Based on SEC Form 4 filings from the past 90 days, CHTP insider trading sentiment is currently bullish with an Alignment Score of 91/100. The net insider flow of $30.1M reflects accumulation, with 91% of volume being purchases.
SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like Chelsea Therapeutics International, Ltd.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At CHTP, we track all Form 4 filings—currently showing 301 transactions from 21 insiders over 90 days.
A 10b5-1 plan allows Chelsea Therapeutics International, Ltd. executives to pre-schedule stock sales when they don't possess material non-public information. At CHTP, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at CHTP appears discretionary, making insider signals more meaningful.
You can monitor Chelsea Therapeutics International, Ltd. (CHTP) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 21 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.
Insider trading at Chelsea Therapeutics International, Ltd. (CHTP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of shares. These individuals must report trades to the SEC within two business days. Currently, 21 insiders are actively trading CHTP stock, having executed 301 transactions in the past 90 days. The most active insider is Josiah T. Austin (Executive), with 117 transactions totaling $18.3M.
Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. Chelsea Therapeutics International, Ltd.'s current score of 91/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $33.5M in purchases versus $3.5M in sales over 90 days, resulting in a net flow of $30.1M.
SEC Form 4 filings are mandatory reports that Chelsea Therapeutics International, Ltd. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At CHTP, the most common type is "M" with 29 occurrences. The most recent Form 4 was filed on Jun 23, 2014 by D. Schwieterman William.
Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At Chelsea Therapeutics International, Ltd., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at CHTP represents discretionary decisions with more informational value.
Track every insider move.
Before the market reacts.
Set alerts for Chelsea Therapeutics International, Ltd. and 40,000+ other insiders.